Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SkinDx is a U.S. dermatopathology laboratory business focused on diagnostic services for dermatologists and patients. The company has provided skin pathology testing and related clinical, molecular, and digital pathology services, with operations centered in Birmingham, Alabama and service coverage across more than fourteen states. In June 2021, SkinDx was acquired by PathGroup, which integrated the business into its broader pathology network while continuing to support SkinDx clients. SkinDx is best characterized as a commercial diagnostic laboratory rather than a therapeutic biotech or drug developer, and it does not appear to maintain a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SkinDx.